Prognostic value of quantitative flow ratio measured immediately after percutaneous coronary intervention for chronic

Zheng Qiao1,2, Zhang-Yu Lin1,2, Qian-Qian Liu2

  • 1State Key Laboratory of Cardiovascular Disease, Beijing, China.

Insights

Quantitative flow ratio (QFR) after percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) predicts patient outcomes. Achieving a post-PCI QFR of 0.91 or higher is associated with significantly better 2-year prognosis.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • The clinical significance of post-percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) in patients undergoing PCI for chronic total occlusion (CTO) remains unclear.
  • Assessing functional outcomes after CTO PCI is crucial for patient management.

Purpose of the Study:

  • To evaluate the impact of post-PCI QFR on 2-year vessel-oriented composite endpoints (VOCEs) in patients with CTO.
  • To determine the optimal QFR cutoff value for predicting adverse events after CTO PCI.

Main Methods:

  • Retrospective analysis of CTO vessels from the PANDA III trial with successful anatomical PCI.
  • Post-PCI QFR was measured, and the primary outcome was 2-year VOCEs (cardiac death, MI, or revascularization).
  • Receiver operator characteristic curve analysis identified the optimal QFR cutoff; Cox models assessed hazard ratios.

Main Results:

  • Of 428 CTO vessels, 353 (82.5%) had analyzable post-PCI QFR. 31 VOCEs (8.7%) occurred at 2 years.
  • The optimal post-PCI QFR cutoff for predicting 2-year VOCEs was 0.91.
  • Vessels with post-PCI QFR < 0.91 (n=91) had a significantly higher incidence of VOCEs (22.0%) compared to those with QFR ≥ 0.91 (n=262) (4.2%), with a hazard ratio of 4.98.

Conclusions:

  • Higher post-PCI QFR values correlate with improved prognosis in coronary CTO interventions.
  • Achieving a functionally optimal PCI result, defined as a post-PCI QFR ≥ 0.91, is associated with better long-term outcomes for patients with CTO lesions.
Abstract